RIO DE JANEIRO — Brazil has authorized medicinal cannabis-primarily based solutions, the country’s pharmaceutical regulator Anvisa stated on Tuesday, becoming the most recent drug-ravaged Latin American nation to sign off on healthcare marijuana.
The new regulations will be published in the country’s official gazette in the subsequent couple of days and come into law 90 days soon after that, Anvisa stated. It also set out precise guidelines for the manufacture, import, sale, packaging, advertising and regulation of the new class of cannabis-primarily based solutions.
Latin America has suffered numerous drug-connected deaths in current decades, and cease-get started moves toward the legalization of healthcare – and even recreational – marijuana in nations like Colombia, Mexico and Uruguay represent a broader reassessment of drug laws in a area extended-typified by aggressive prohibition.
Brazil’s selection is also component of a gradually altering worldwide view toward illegal drugs, with expanding investment into the medicinal added benefits of marijuana and other narcotics.
Nonetheless, in regional terms, Brazil could be arriving late, with each Uruguay and Colombia possessing each legalized healthcare marijuana and actively operating toward gaining a firm foothold in the booming multibillion-dollar worldwide marketplace.
Uruguay was the initially nation to legalize the expanding, sale and smoking of marijuana in December 2013 in a pioneering social experiment closely watched by other nations debating drug liberalization.
Colombia has also legalized healthcare marijuana, even though in Mexico, the supreme court ordered the country’s wellness ministry to speed up its issuance of healthcare marijuana regulations, with recreational cannabis also getting discussed by lawmakers.
Anvisa stated that cannabis-primarily based solutions will only be out there for sale in registered pharmacies, and with a prescription.
(Reporting by Gabriel Stargardter Editing by Andrea Ricci)